Back to XENE
Candriam S.C.A. XENE Position History
Xenon Pharmaceuticals Inc. • Healthcare
Quarters held
6
Latest value
$17.2M
Q3 2026
Peak value
$27.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $15.9M |
| Q4 2025 | $18.7M |
| Q4 2025 | $18.7M |
| Q1 2026 | $27.7M |
| Q2 2026 | $27.9M |
| Q3 2026 | $17.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $17.2M | 461.5K | — | — |
| Q2 2026 | $27.9M | 462.8K | — | — |
| Q1 2026 | $27.7M | 476.5K | — | — |
| Q4 2025 | $18.7M | 417.4K | — | — |
| Q4 2025 | $18.7M | 417.4K | — | — |
| Q3 2025 | $15.9M | 396.6K | — | — |
Other funds holding XENE
$143.4M
$136.9M
$118.9M
$118.9M
$100M
$89.1M